Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-13-000010
Filing Date
2013-01-29
Accepted
2013-01-29 10:25:46
Documents
1
Period of Report
2013-01-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3202
  Complete submission text file 0001288123-13-000010.txt   4663
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Issuer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ANTIGENICS INC. 162 FIFTH AVE., SUITE 900 NEW YORK NY 10010
Business Address
Wentworth Kerry (Reporting) CIK: 0001369453 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 13553858